Systematic review and metaanalysis on nonclassic cardiovascular biomarkers after hypertensive pregnancy disorders

American Journal of Obstetrics and Gynecology

Volumn 211, Issue 4, 2014, Pages 373.e1-373.e9

  Visser, Sanne ^a,b   Hermes, Wietske ^a,d   Ket, Johannes C F ^a   Otten, René H J ^a   Van Pampus, Maria G ^b   Bloemenkamp, Kitty W M ^f   Franx, Arie ^e   Mol, Ben W ^c   De Groot, Christianne J M ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d MEDICAL CENTER HAAGLANDEN   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

cardiovascular risk; hypertensive pregnancy disorders; preeclampsia; pregnancy induced hypertension

Indexed keywords

BIOLOGICAL MARKER; D DIMER; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 6; VASCULAR CELL ADHESION MOLECULE 1; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CINAHL; COHORT ANALYSIS; EMBASE; HUMAN; INFLAMMATION; MATERNAL HYPERTENSION; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THROMBOSIS; BLOOD; FEMALE; HYPERTENSION; PREGNANCY; STATISTICAL MODEL;

BIOMARKERS; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; HYPERTENSION; HYPERTENSION, PREGNANCY-INDUCED; MODELS, STATISTICAL; PREGNANCY;

EID: 84907702878     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2014.03.032     Document Type: Article

References (53)

1. G. Burell, and B. Granlund Women's hearts need special treatment Int J Behav Med 9 2002 228 242
2. M. Stramba-Badiale, K.M. Fox, and S.G. Priori Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology Eur Heart J 27 2006 994 1005
3. P.S. Douglas, and G.S. Ginsburg The evaluation of chest pain in women N Engl J Med 334 1996 1311 1315
4. V. Vaccarino, L. Badimon, and R. Corti Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? Position paper from the Working Group on Coronary Pathophysiology and Microcirculation of the European Society of Cardiology Cardiovasc Res 90 2011 9 17
5. A.K. Sullivan, D.R. Holdright, C.A. Wright, J.L. Sparrow, D. Cunningham, and K.M. Fox Chest pain in women: clinical, investigative, and prognostic features BMJ 308 1994 883 886
6. C. Arslanian-Engoren Women's risk factors and screening for coronary heart disease J Obstet Gynecol Neonatal Nurs 40 2011 337 346 quiz 346-7
7. D. Berks, M. Hoedjes, H. Raat, J. Duvekot, E. Steegers, and J. Habbema Risk of cardiovascular disease after pre-eclampsia and the effect of lifestyle interventions: a literature-based study BJOG 120 2013 924 931
8. N. Sattar, and A. Greer Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 325 2002 157 160
9. A.J. Buurma, R.J. Turner, and J.H. Driessen Genetic variants in pre-eclampsia: a meta-analysis Hum Reprod Update 19 2013 289 303
10. W. Hermes, J.C. Ket, and M.G. van Pampus Biochemical cardiovascular risk factors after hypertensive pregnancy disorders: a systematic review and meta-analysis Obstet Gynecol Surv 67 2012 793 809
11. Y. Ge, and T.J. Wang Identifying novel biomarkers for cardiovascular disease risk prediction J Intern Med 272 2012 430 439
12. L.G. Gilstrap, and T.J. Wang Biomarkers and cardiovascular risk assessment for primary prevention: an update Clin Chem 58 2012 72 82
13. O. Dotsenko, J. Chackathayil, J.V. Patel, P.S. Gill, and G.Y. Lip Candidate circulating biomarkers for the cardiovascular disease continuum Curr Pharm Des 14 2008 2445 2461
14. S. Masoura, I.A. Kalogiannidis, and G. Gitas Biomarkers in pre-eclampsia: a novel approach to early detection of the disease J Obstet Gynaecol 32 2012 609 616
15. M.U. Baumann, N.A. Bersinger, and D.V. Surbek Serum markers for predicting pre-eclampsia Mol Aspects Med 28 2007 227 244
16. M.A. Brown, M.D. Lindheimer, and M. de Swiet The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP) Hypertens Pregnancy 20 2001 IX XIV
17. B.M. Sibai Diagnosis and management of gestational hypertension and preeclampsia Obstet and Gynecol 102 2003 181 192
18. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
19. L. Deng, K. Bremme, L.O. Hansson, and M. Blombäck Plasma levels of von Willebrand factor and fibronectin as markers of persisting endothelial damage in preeclampsia Obstet Gynecol 84 1994 941 945
20. K. Bremme, and M. Blombäck Hemostatic abnormalities may predict chronic hypertension after preeclampsia Gynecol Obstet Invest 41 1996 20 26
21. H. Laivuori, R. Kaaja, E.M. Rutanen, L. Viinikka, and O. Ylikorkala Evidence of high circulating testosterone in women with prior preeclampsia J Clin Endocrinol Metab 83 1998 344 347
22. A.E. Barden, L.J. Beilin, J. Ritchie, B.N. Walters, and C. Michael Does a predisposition to the metabolic syndrome sensitize women to develop pre-eclampsia? J Hypertens 17 1999 1307 1315
23. S. He, A. Silveira, A. Hamsten, M. Blombäck, and K. Bremme Haemostatic, endothelial and lipoprotein parameters and blood pressure levels in women with a history of preeclampsia Thromb Haemost 81 1999 538 542
24. J.C. Chambers, L. Fusi, I.S. Malik, D.O. Haskard, M. De Swiet, and J.S. Kooner Association of maternal endothelial dysfunction with preeclampsia JAMA 285 2001 1607 1612
25. N. Sattar, J. Ramsay, L. Crawford, H. Cheyne, and I.A. Greer Classic and novel risk factor parameters in women with a history of preeclampsia Hypertension 42 2003 39 42
26. M. Vickers, I. Ford, and R. Morrison Markers of endothelial activation and atherothrombosis in women with history of preeclampsia or gestational hypertension Thromb Haemost 90 2003 1192 1197
27. D.J. Freeman, F. McManus, and E.A. Brown Short- and long-term changes in plasma inflammatory markers associated with preeclampsia Hypertension 44 2004 708 714
28. M.T. Raijmakers, E.M. Roes, P.L. Zusterzeel, E.A. Steegers, and W.H. Peters Thiol status and antioxidant capacity in women with a history of severe pre-eclampsia BJOG 111 2004 207 212
29. M. Wolf, C.A. Hubel, and C. Lam Preeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistance J Clin Endocrinol Metab 89 2004 6239 6243
30. G. Paradisi, A. Biaggi, and R. Savone Cardiovascular risk factors in healthy women with previous gestational hypertension J Clin Endocrinol Metab 91 2006 1233 1238
31. J. Girouard, Y. Giguère, J.M. Moutquin, and J.C. Forest Previous hypertensive disease of pregnancy is associated with alterations of markers of insulin resistance Hypertension 49 2007 1056 1062
32. R.R. Hamad, M.J. Eriksson, A. Silveira, A. Hamsten, and K. Bremme Decreased flow-mediated dilation is present 1 year after a pre-eclamptic pregnancy J Hypertens 25 2007 2301 2307
33. B.B. van Rijn, A. Franx, and E.A. Steegers Maternal TLR4 and NOD2 gene variants, pro-inflammatory phenotype and susceptibility to early-onset preeclampsia and HELLP syndrome PLoS One 3 2008 e1865
34. K.H. Lampinen, M. Rönnback, P.H. Groop, and R.J. Kaaja A relationship between insulin sensitivity and vasodilation in women with a history of preeclamptic pregnancy Hypertension 52 2008 394 401
35. A. Portelinha, A.S. Cerdeira, and L. Belo Haemostatic factors in women with history of preeclampsia Thromb Res 124 2009 52 56
36. A. Portelinha, L. Belo, E. Tejera, and I. Rebelo Adhesion molecules (VCAM-1 and ICAM-1) and C-reactive protein in women with history of preeclampsia Acta Obstet Gynecol Scand 87 2008 969 971
37. S.M. Coffeng, J. Blaauw, and E.T. Souwer Skin autofluorescence as marker of tissue advanced glycation end-products accumulation in formerly preeclamptic women Hypertens Pregnancy 30 2011 231 242
38. H. Stepan, A. Philipp, and I. Roth Serum levels of the adipokine chemerin are increased in preeclampsia during and 6 months after pregnancy Regul Pept 168 2011 69 72
39. I.P. Gaugler-Senden, J.T. Tamsma, C. van der Bent, R. Kusters, E.A. Steegers, and C.J. de Groot Angiogenic factors in women ten years after severe very early onset preeclampsia PLoS One 7 2012 e43637
40. L. Mosca Guidelines for prevention of cardiovascular disease in women: a summary of recommendations Prev Cardiol 10 Suppl 4 2007 19 25
41. J. Perk, G. De Backer, H. Gohlke European Association for Cardiovascular Prevention and Rehabilitation (EACPR) European guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Int J Behav Med 19 2012 403 488
42. A.J. Martí-Carvajal, I. Solà, D. Lathyris, D.E. Karakitsiou, and D. Simancas-Racines Homocysteine-lowering interventions for preventing cardiovascular events Cochrane Database Syst Rev 1 2013 CD006612
43. H.S. Ros, S. Cnattingius, and L. Lipworth Comparison of risk factors for preeclampsia and gestational hypertension in a population-based cohort study Am J Epidemiol 147 1998 1062 1070
44. D. Raymond, and E. Peterson A critical review of early-onset and late-onset preeclampsia Obstet Gynecol Surv 66 2011 497 506
45. P. Bogdanski, E. Miller-Kasprzak, and D. Pupek-Musialik Plasma total homocysteine is a determinant of carotid intima-media thickness and circulating endothelial progenitor cells in patients with newly diagnosed hypertension Clin Chem Lab Med 50 2012 1107 1113
46. W. Ruijter, R.G. Westendorp, and W.J. Assendelft Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study BMJ 338 2009 a3083
47. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288:2015-22.
48. B. Demir, S. Demir, and S. Pasa The role of homocysteine, asymmetric dimethylarginine and nitric oxide in pre-eclampsia J Obstet Gynaecol 32 2012 525 528
49. S. Masoura, I.A. Kalogiannidis, G. Gitas, A. Goutsioulis, E. Koiou, A. Athanasiadis, and N. Vavatsi Biomarkers in pre-eclampsia: a novel approach to early detection of the disease J Obstet Gynaecol 32 2012 609 616
50. Y.M. Smulders, and H.J. Blom The homocysteine controversy J Inherit Metab Dis 34 2011 93 99
51. J.D. Fontes, J.F. Yamamoto, and M.G. Larson Clinical correlates of change in inflammatory biomarkers: the Framingham Heart Study Atherosclerosis 228 2013 217 223
52. J.C. Forest, M. Charland, and J. Massé Candidate biochemical markers for screening of pre-eclampsia in early pregnancy Clin Chem Lab Med 50 2012 973 984
53. S. Aref, and H. Goda Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia Hematology 18 2013 237 241